Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sisram Medical Ltd. ( (HK:1696) ) has shared an announcement.
Sisram Medical Ltd announced that the commercialization of its product, DAXXIFY® (DaxibotulinumtoxinA-lanm), in Mainland China is progressing steadily. The company is actively working on regulatory filings, market access, and building a professional team to support the product’s launch, expressing strong confidence in its market potential.
More about Sisram Medical Ltd.
Sisram Medical Ltd is a company incorporated in Israel, operating in the medical industry. It focuses on the commercialization of medical products, with a particular emphasis on the Chinese market.
Average Trading Volume: 1,106,939
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.82B
For detailed information about 1696 stock, go to TipRanks’ Stock Analysis page.